{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:00:16Z","timestamp":1788886816359,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/Med\/30\/SP11016\/2015"],"award-info":[{"award-number":["BT\/Med\/30\/SP11016\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/001566"],"award-info":[{"award-number":["EMR\/2017\/001566"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cyto.2024.156535","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T08:29:31Z","timestamp":1707208171000},"page":"156535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma"],"prefix":"10.1016","volume":"176","author":[{"given":"Swati","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Lathoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia B.","family":"Umdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-7850","authenticated-orcid":false,"given":"Ellora","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156535_b0005","doi-asserted-by":"crossref","first-page":"iv1-iv86","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cyto.2024.156535_b0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2024.156535_b0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cyto.2024.156535_b0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156535_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cyto.2024.156535_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228563","article-title":"A New Twist in Protein Kinase B\/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance","volume":"21","author":"Gotting","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cyto.2024.156535_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: Navigating the Network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156535_b0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27293","article-title":"Akt regulation of glycolysis mediates bioenergetic stability in epithelial cells","volume":"6","author":"Hung","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.cyto.2024.156535_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.920017","article-title":"Targeting AKT-Dependent Regulation of Antioxidant Defense Sensitizes AKT-E17K Expressing Cancer Cells to Ionizing Radiation","volume":"12","author":"Goetting","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cyto.2024.156535_b0050","doi-asserted-by":"crossref","first-page":"56081","DOI":"10.18632\/oncotarget.9760","article-title":"Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer","volume":"8","author":"Anderson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2024.156535_b0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2024.156535_b0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yexcr.2015.11.016","article-title":"TNFalpha driven HIF-1alpha-hexokinase II axis regulates MHC-I cluster stability through actin cytoskeleton","volume":"340","author":"Ghosh","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cyto.2024.156535_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ebiom.2018.12.048","article-title":"Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism","volume":"40","author":"Dunn","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cyto.2024.156535_b0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/cdd.2014.173","article-title":"Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy","volume":"22","author":"Roberts","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cyto.2024.156535_b0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/ars.2013.5489","article-title":"Effects of ionizing radiation on biological molecules\u2013mechanisms of damage and emerging methods of detection","volume":"21","author":"Reisz","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cyto.2024.156535_b0080","doi-asserted-by":"crossref","unstructured":"E. Mullarky, L.C. Cantley, Diverting Glycolysis to Combat Oxidative Stress, in: K. Nakao, N. Minato, S. Uemoto (Eds.), Innovative Medicine: Basic Research and Development (Tokyo, 2015), pp. 3-23, 10.1007\/978-4-431-55651-0_1.","DOI":"10.1007\/978-4-431-55651-0_1"},{"key":"10.1016\/j.cyto.2024.156535_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cyto.2024.156535_b0090","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1074\/jbc.M117.816785","article-title":"Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells","volume":"293","author":"Sheikh","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2024.156535_b0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuint.2009.10.003","article-title":"TNFalpha induced oxidative stress dependent Akt signaling affects actin cytoskeletal organization in glioma cells","volume":"56","author":"Ghosh","year":"2010","journal-title":"Neurochem Int"},{"key":"10.1016\/j.cyto.2024.156535_b0100","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/ijc.23261","article-title":"Interleukin-6 activates PI3K\/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival","volume":"122","author":"Wegiel","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cyto.2024.156535_b0105","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.2147\/IJN.S101285","article-title":"Upregulation of Akt\/NF-kappaB-regulated inflammation and Akt\/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle","volume":"11","author":"Tang","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cyto.2024.156535_b0110","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO;2-X","article-title":"IL-1beta-induced phosphorylation of PKB\/Akt depends on the presence of IRAK-1","volume":"32","author":"Neumann","year":"2002","journal-title":"European J. Immunol."},{"key":"10.1016\/j.cyto.2024.156535_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155828","article-title":"Interleukin-8: An evolving chemokine","volume":"153","author":"Matsushima","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156535_b0120","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259188","article-title":"YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas","volume":"134","author":"Patrick","year":"2021","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cyto.2024.156535_b0125","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1080\/15548627.2023.2165757","article-title":"PRMT1 driven PTX3 regulates ferritinophagy in glioma","volume":"19","author":"Lathoria","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.cyto.2024.156535_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00001-18","article-title":"Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-beta-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression","volume":"38","author":"Gowda","year":"2018","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cyto.2024.156535_b0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.cyto.2024.156535_b0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.yexcr.2017.09.028","article-title":"Reciprocal role of SIRT6 and Hexokinase 2 in the regulation of autophagy driven monocyte differentiation","volume":"360","author":"Singh","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cyto.2024.156535_b0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.freeradbiomed.2009.04.031","article-title":"Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation","volume":"47","author":"Dixit","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cyto.2024.156535_b0150","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.cyto.2024.156535_b0155","doi-asserted-by":"crossref","first-page":"e52707","DOI":"10.1371\/journal.pone.0052707","article-title":"Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156535_b0160","doi-asserted-by":"crossref","first-page":"e12780","DOI":"10.1111\/nan.12780","article-title":"AKT1(E17K) -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363","volume":"48","author":"John","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.cyto.2024.156535_b0165","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1158\/1535-7163.MCT-15-0230","article-title":"Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors","volume":"14","author":"Davies","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cyto.2024.156535_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw320","article-title":"Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363","volume":"109","author":"Weller","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cyto.2024.156535_b0175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1535-7163.MCT-11-0824-T","article-title":"Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background","volume":"11","author":"Davies","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cyto.2024.156535_b0180","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3892\/ol.2016.4111","article-title":"A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.cyto.2024.156535_b0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nchembio.183","article-title":"Inhibitor hijacking of Akt activation","volume":"5","author":"Okuzumi","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cyto.2024.156535_b0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.urolonc.2013.10.018","article-title":"Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells","volume":"32","author":"Bi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.cyto.2024.156535_b0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41419-018-0745-0","article-title":"CXCR1\/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis","volume":"9","author":"Du","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.cyto.2024.156535_b0200","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/15384047.2015.1056409","article-title":"Activation of IL-8 via PI3K\/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells","volume":"16","author":"Wang","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cyto.2024.156535_b0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00109-011-0807-6","article-title":"Involvement of TNFalpha-induced TLR4-NF-kappaB and TLR4-HIF-1alpha feed-forward loops in the regulation of inflammatory responses in glioma","volume":"90","author":"Tewari","year":"2012","journal-title":"J Mol Med (berl)"},{"key":"10.1016\/j.cyto.2024.156535_b0210","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2016.05.076","article-title":"Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan","volume":"166","author":"Wolf","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156535_b0215","doi-asserted-by":"crossref","first-page":"eade7652","DOI":"10.1126\/sciimmunol.ade7652","article-title":"Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation","volume":"8","author":"Baik","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.cyto.2024.156535_b0220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.4049\/jimmunol.1701522","article-title":"Toll-like Receptor 4-Induced Glycolytic Burst in Human Monocyte-Derived Dendritic Cells Results from p38-Dependent Stabilization of HIF-1alpha and Increased Hexokinase II Expression","volume":"201","author":"Perrin-Cocon","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2024.156535_b0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-019-2035-x","article-title":"ROS-mediated inactivation of the PI3K\/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin","volume":"10","author":"Wen","year":"2019","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.cyto.2024.156535_b0230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2009.05.024","article-title":"ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells","volume":"47","author":"Cao","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cyto.2024.156535_b0235","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1038\/emm.2016.119","article-title":"ROS homeostasis and metabolism: a critical liaison for cancer therapy","volume":"48","author":"Kim","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cyto.2024.156535_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050722","article-title":"Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas","volume":"17","author":"Tsai","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cyto.2024.156535_b0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18632\/genesandcancer.4","article-title":"SOD1, an unexpected novel target for cancer therapy","volume":"5","author":"Papa","year":"2014","journal-title":"Genes Cancer"},{"key":"10.1016\/j.cyto.2024.156535_b0250","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.cyto.2024.156535_b0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","article-title":"Targeting Akt in cancer for precision therapy","volume":"14","author":"Hua","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cyto.2024.156535_b0260","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1517\/13543784.2010.520701","article-title":"Akt inhibitors in clinical development for the treatment of cancer","volume":"19","author":"Pal","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.cyto.2024.156535_b0265","doi-asserted-by":"crossref","first-page":"e0044920","DOI":"10.1128\/MCB.00449-20","article-title":"Rewiring of Lactate-Interleukin-1beta Autoregulatory Loop with Clock-Bmal1: a Feed-Forward Circuit in Glioma","volume":"41","author":"Gowda","year":"2021","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cyto.2024.156535_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.703681","article-title":"Metabolic Modifications, Inflammation, and Cancer Immunotherapy","volume":"11","author":"Zheng","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.cyto.2024.156535_b0275","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1038\/cddis.2014.179","article-title":"Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism","volume":"5","author":"Dixit","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.cyto.2024.156535_b0280","doi-asserted-by":"crossref","first-page":"e2213","DOI":"10.1038\/cddis.2016.117","article-title":"Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma","volume":"7","author":"Ahmad","year":"2016","journal-title":"Cell Death & Disease"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:50:15Z","timestamp":1760910615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":56,"alternative-id":["S1043466624000383"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156535","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156535"}}